Orient Europharma Co Ltd (4120) — Cash Flow Reinvestment Rate
Orient Europharma Co Ltd (4120) has a Cash Flow Reinvestment Rate of 44.08x as of June 2025, reinvesting NT$1.47 Billion (capex NT$89.03 Million plus investments NT$1.38 Billion) from operating cash flow of NT$33.25 Million. Explore Orient Europharma Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Orient Europharma Co Ltd Cash Flow Reinvestment Rate (2015–2023)
Historical reinvestment intensity for Orient Europharma Co Ltd across 8 annual periods. Also explore balance sheet size of Orient Europharma Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Orient Europharma Co Ltd (2015–2023)
Year-by-year capital reinvestment analysis for Orient Europharma Co Ltd. For live market cap and broader valuation context, see Orient Europharma Co Ltd (4120) total market value.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 5.44x | NT$351.83 Million | NT$64.67 Million | NT$100.70 Million | ▼ -75.1% |
| 2021 | 21.89x | NT$1.70 Billion | NT$77.65 Million | NT$1.56 Billion | ▲ +3647.9% |
| 2020 | 0.58x | NT$355.35 Million | NT$608.55 Million | NT$232.78 Million | ▲ +4.4% |
| 2019 | 0.56x | NT$127.14 Million | NT$227.37 Million | NT$124.98 Million | ▼ -36.0% |
| 2018 | 0.87x | NT$202.21 Million | NT$231.31 Million | NT$201.61 Million | ▲ +9.7% |
| 2017 | 0.80x | NT$478.86 Million | NT$601.08 Million | NT$367.66 Million | ▼ -85.4% |
| 2016 | 5.47x | NT$608.30 Million | NT$111.24 Million | NT$224.81 Million | ▲ +912.9% |
| 2015 | 0.54x | NT$347.66 Million | NT$643.97 Million | NT$229.54 Million | — |